Clinical Trial Update: Postconditioning by Cyclosporin A in Pulmonary Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating postconditioning with Cyclosporin A in pulmonary transplantation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Transplantation

Drugs mentioned

• Cyclosporin A (cyclosporine)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Lung Transplantation | Phase 3 | Status: WITHDRAWN